Efficacy and Safety of GLP-1 and Dual GIP/GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension: A Systematic Review and Meta-Analysis.

Regarding visual outcomes, a near‐significant trend toward improved visual acuity with GLP‐1 RA treatment was observed at 3 months (MD = −0.08; 95% CI: −0.17 to 0.01; p = 0.07; 2 studies; I 2 = 0%; p for Cochran's Q = 0.45; Figure 3a ); however, this trend did not reach statistical significance at the end of follow‐up (MD = −0.04; 95% CI: −0.20 to 0.12; 2 studies; p = 0.63; I 2 = 53%; p for Cochran's Q = 0.14; Figure 3b ).

also in 111,027 other papers